Login / Signup

'We cannot paint them all with the same brush': the need for a better definition of patients with myelodysplastic syndromes for clinical trial design.

Carmelo GurnariValeria Visconte
Published in: British journal of haematology (2021)
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • placebo controlled